New Treatment for TED - Summary - MDSpire

New Treatment for TED

Dr Michael Yen discusses Lumvoa’s recent FDA approval for active and chronic thyroid eye disease

Share

The Ophthalmologist

The Ophthalmologist

Charity "profoundly concerned" about Trump Administration proposal

Journal Of Medical Internet Research

The Ophthalmologist

Large US database study suggests previous pars plana vitrectomy may substantially increase likelihood of pseudophakic cystoid macular edema